Novartis
Novartis is a Swiss multinational pharmaceutical company known for its innovative medicines and commitment to research and development. It has a strong presence in the global healthcare market and has been recognized for its contributions to various therapeutic areas, including oncology and cardiovascular health.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 2 | 5.00 | 0.14% | +10% | 8,654,622 | 13,409 | $700,000 | 1,085$ |
| Germany | 1 | 5.00 | 0.06% | +0% | 83,783,942 | 51,433 | $3,845,000 | 2,360$ |
| Totals | 3 | 92,438,564 | 64,842 | $4,545,000 | 3,445$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Germany:
Novartis is also under pressure from Trump to reduce their prices in the USA.
5
Switzerland:
In Switzerland, ABB and Novartis are reporting this Thursday.
5
Switzerland:
Novartis has not yet made any site selections for its investment program in the USA.
5
Switzerland:
Novartis is not expected to launch products with a significant impact on the market.
4
Canada:
Swiss pharma company Novartis pledged $23 billion in investments.
7
France:
Novartis is another Swiss company that has joined in announcing significant investments in the U.S.
7
Switzerland:
Novartis is a pharmaceutical company that may be affected by tariffs.
5
Switzerland:
Novartis is also expected to make efforts to optimize their US production to avoid import tariffs.
6
Switzerland:
Novartis is another company in the fund's portfolio.
7
Switzerland:
Novartis has experienced a stock increase of 10 percent.
7